59 related articles for article (PubMed ID: 24241172)
1. Characterization of anti-Tn-antigen MLS128 binding proteins involved in inhibiting the growth of human colorectal cancer cells.
Zamri N; Masuda N; Oura F; Kabayama K; Yajima Y; Nakada H; Yamamoto K; Fujita-Yamaguchi Y
Biosci Trends; 2013 Oct; 7(5):221-9. PubMed ID: 24241172
[TBL] [Abstract][Full Text] [Related]
2. Effects of two monoclonal antibodies, MLS128 against Tn-antigen and 1H7 against insulin-like growth factor-I receptor, on the growth of colon cancer cells.
Zamri N; Masuda N; Oura F; Yajima Y; Nakada H; Fujita-Yamaguchi Y
Biosci Trends; 2012 Dec; 6(6):303-12. PubMed ID: 23337790
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility to proteases of anti-Tn-antigen MLS128 binding glycoproteins expressed in human colon cancer cells.
Oura F; Yajima Y; Nakata M; Taniue K; Akiyama T; Nakada H; Yamamoto K; Fujita-Yamaguchi Y
Biosci Trends; 2015 Feb; 9(1):49-55. PubMed ID: 25787909
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of cancer cell growth by anti-Tn monoclonal antibody MLS128.
Morita N; Yajima Y; Asanuma H; Nakada H; Fujita-Yamaguchi Y
Biosci Trends; 2009 Feb; 3(1):32-7. PubMed ID: 20103942
[TBL] [Abstract][Full Text] [Related]
5. MLS128 antibody-induced suppression of colon cancer cell growth is mediated by a desmocollin and a 110 kDa glycoprotein.
Shuck SC; Hong T; Kalkum M; Igarashi R; Kajiya K; Termini J; Yamamoto K; Fujita-Yamaguchi Y
Biosci Trends; 2019 Jul; 13(3):216-224. PubMed ID: 31168022
[TBL] [Abstract][Full Text] [Related]
6. Surface plasmon resonance and NMR analyses of anti Tn-antigen MLS128 monoclonal antibody binding to two or three consecutive Tn-antigen clusters.
Matsumoto-Takasaki A; Hanashima S; Aoki A; Yuasa N; Ogawa H; Sato R; Kawakami H; Mizuno M; Nakada H; Yamaguchi Y; Fujita-Yamaguchi Y
J Biochem; 2012 Mar; 151(3):273-82. PubMed ID: 22161472
[TBL] [Abstract][Full Text] [Related]
7. Prevention of cytokine-induced apoptosis by insulin-like growth factor-I is independent of cell adhesion molecules in HT29-D4 colon carcinoma cells-evidence for a NF-kappaB-dependent survival mechanism.
Garrouste F; Remacle-Bonnet M; Fauriat C; Marvaldi J; Luis J; Pommier G
Cell Death Differ; 2002 Jul; 9(7):768-79. PubMed ID: 12058282
[TBL] [Abstract][Full Text] [Related]
8. RAV12 accelerates the desensitization of Akt/PKB pathway of insulin-like growth factor I receptor signaling in COLO205.
Li JC; Li R
Cancer Res; 2007 Sep; 67(18):8856-64. PubMed ID: 17875727
[TBL] [Abstract][Full Text] [Related]
9. Construction and expression of anti-Tn-antigen-specific single-chain antibody genes from hybridoma producing MLS128 monoclonal antibody.
Yuasa N; Ogawa H; Koizumi T; Tsukamoto K; Matsumoto-Takasaki A; Asanuma H; Nakada H; Fujita-Yamaguchi Y
J Biochem; 2012 Apr; 151(4):371-81. PubMed ID: 22318767
[TBL] [Abstract][Full Text] [Related]
10. Recombinant human insulin-like growth factor binding protein 3 inhibits growth of human epidermal growth factor receptor-2-overexpressing breast tumors and potentiates herceptin activity in vivo.
Jerome L; Alami N; Belanger S; Page V; Yu Q; Paterson J; Shiry L; Pegram M; Leyland-Jones B
Cancer Res; 2006 Jul; 66(14):7245-52. PubMed ID: 16849573
[TBL] [Abstract][Full Text] [Related]
11. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
[TBL] [Abstract][Full Text] [Related]
12. NO donor and MEK inhibitor synergistically inhibit proliferation and invasion of cancer cells.
Furuhashi S; Sugita H; Takamori H; Horino K; Nakahara O; Okabe H; Miyake K; Tanaka H; Beppu T; Baba H
Int J Oncol; 2012 Mar; 40(3):807-15. PubMed ID: 22025280
[TBL] [Abstract][Full Text] [Related]
13. Co-targeting the EGFR and IGF-IR with anti-EGFR monoclonal antibody ICR62 and the IGF-IR tyrosine kinase inhibitor NVP-AEW541 in colorectal cancer cells.
Cunningham MP; Thomas H; Marks C; Green M; Fan Z; Modjtahedi H
Int J Oncol; 2008 Nov; 33(5):1107-13. PubMed ID: 18949375
[TBL] [Abstract][Full Text] [Related]
14. Growth inhibition of insulin-like growth factor I receptor monoclonal antibody to human colorectal cancer cells.
Zhang Y; Zhang Y
Cancer Invest; 2008; 26(3):230-6. PubMed ID: 18317963
[TBL] [Abstract][Full Text] [Related]
15. Potential autocrine role of insulin-like growth factor II during suramin-induced differentiation of HT29-D4 human colonic adenocarcinoma cell line.
Pommier GJ; Garrouste FL; el Atiq F; Roccabianca M; Marvaldi JL; Remacle-Bonnet MM
Cancer Res; 1992 Jun; 52(11):3182-8. PubMed ID: 1375536
[TBL] [Abstract][Full Text] [Related]
16. Purification of a colon cancer cell growth inhibitor and its identification as an insulin-like growth factor binding protein.
Culouscou JM; Shoyab M
Cancer Res; 1991 Jun; 51(11):2813-9. PubMed ID: 1709585
[TBL] [Abstract][Full Text] [Related]
17. Tyrosine kinase-independent activation of extracellular-regulated kinase (ERK) 1/2 by the insulin-like growth factor-1 receptor.
Perrault R; Wright B; Storie B; Hatherell A; Zahradka P
Cell Signal; 2011 Apr; 23(4):739-46. PubMed ID: 21215800
[TBL] [Abstract][Full Text] [Related]
18. Neurotensin-induced Erk1/2 phosphorylation and growth of human colonic cancer cells are independent from growth factors receptors activation.
Massa F; Tormo A; Béraud-Dufour S; Coppola T; Mazella J
Biochem Biophys Res Commun; 2011 Oct; 414(1):118-22. PubMed ID: 21945442
[TBL] [Abstract][Full Text] [Related]
19. Regulation of vitamin D receptor expression via estrogen-induced activation of the ERK 1/2 signaling pathway in colon and breast cancer cells.
Gilad LA; Bresler T; Gnainsky J; Smirnoff P; Schwartz B
J Endocrinol; 2005 Jun; 185(3):577-92. PubMed ID: 15930183
[TBL] [Abstract][Full Text] [Related]
20. Targeting of insulin-like growth factor-I receptor with a monoclonal antibody inhibits growth of hepatic metastases from human colon carcinoma in mice.
Bauer TW; Fan F; Liu W; Camp ER; Yang A; Somcio RJ; Bucana CD; Singh R; Ellis LM
Ann Surg Oncol; 2007 Oct; 14(10):2838-46. PubMed ID: 17653802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
